Product
Help
Pricing
About
Jobs
Log in
Get started
Institution
Add to collection
Arvelle Therapeutics (Switzerland)
Alternate names:
Arvelle Therapeutics GmbH,
Arvelle Therapeutics Inc.,
Arvelle Therapeutics International Gmbh,
Arvelle Therapeutics, Inc.
ROR:
049kbkm36
OpenAlex ID:
I4405272517
The burden of epilepsy and unmet need in people with focal seizures
2022
·
Persefoni Ioannou
, Daniella L. Foster
, et al.
·
Brain and Behavior
·
189
Mapping analysis to predict SF-6D utilities from health outcomes in people with focal epilepsy
2022
·
India Flint
, Jasmina Medjedovic
, et al.
·
The European Journal of Health Economics
·
14
Quality of life study for caregivers of people with uncontrolled focal-onset seizures
2021
·
Ioana-Alexandra Soare
, India Flint
, et al.
·
Journal of Medical Economics
·
11
163 Long-term safety of adjunctive cenobamate in patients with uncontrolled focal seizures
2022
·
Irene Garcia Morales
, Martin J Brodie
, et al.
·
Journal of Neurology Neurosurgery & Psychiatry
·
1
155 Long-term efficacy of adjunctive cenobamate in patients with uncontrolled focal seizures
2022
·
Bernhard Steinhoff
, Martin Brodie
, et al.
·
Journal of Neurology Neurosurgery & Psychiatry
·
1
Dataset for "Longitudinal Peripheral DNA Methylation Remodeling Following Ketamine-Assisted Psychotherapy in Major Depressive Disorder"
2026
·
Nepton, Arghavan
, Faber, Sonya
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
157 Efficacy of adjunctive cenobamate: post-hoc analysis in patients grouped by concomitant anti-epileptic drug type
2022
·
Christian Brandt
, Jose Serratosa
, et al.
·
Journal of Neurology Neurosurgery & Psychiatry
147 Long-term cenobamate retention in people with focal onset seizures: pooled data from open-label studies
2022
·
Josemir W Sander
, Elena Alvarez-Baron
, et al.
·
Journal of Neurology Neurosurgery & Psychiatry
PND69 The Burden of Illness and Unmet Need in Patients with Drug-Resistant Focal-Onset Seizures in Epilepsy
2020
·
D. Foster
, R. Miller
, et al.
·
Value in Health
Cénobamate, un nouveau médicament anti-épileptique doté d’un double mécanisme d’action unique et complémentaire
2020
·
Elena Alvarez-Baron
, Amelie Lothe
, et al.
·
Revue Neurologique
Show more works
View as search
Works count:
10
Citation count:
495
Year
Topic
Type